Brisander M - Search Results

1

Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.

Johansson G, Sundquist S, Nordvall G, Nilsson BM, Brisander M, Nilvebrant L, Hacksell U. Johansson G, et al. Among authors: brisander m. J Med Chem. 1997 Nov 7;40(23):3804-19. doi: 10.1021/jm970346t. J Med Chem. 1997. PMID: 9371246

2

Stereoisomers of 3-(2,3-dihydrobenzofuran-2-yl)quinuclidine: preparation and muscarinic receptor affinities.

Johansson G, Brisander M, Sundquist S, Hacksell U. Johansson G, et al. Among authors: brisander m. Chirality. 1998;10(9):813-20. doi: 10.1002/(SICI)1520-636X(1998)10:9<813::AID-CHIR7>3.0.CO;2-G. Chirality. 1998. PMID: 9839431

3

Derivatives of (R)-1,11-methyleneaporphine: synthesis, structure, and interactions with G-protein coupled receptors.

Linnanen T, Brisander M, Unelius L, Sundholm G, Hacksell U, Johansson AM. Linnanen T, et al. Among authors: brisander m. J Med Chem. 2000 Apr 6;43(7):1339-49. doi: 10.1021/jm9911433. J Med Chem. 2000. PMID: 10753471

4

Atropisomeric derivatives of 2',6'-disubstituted (R)-11-phenylaporphine: selective serotonin 5-HT(7) receptor antagonists.

Linnanen T, Brisander M, Unelius L, Rosqvist S, Nordvall G, Hacksell U, Johansson AM. Linnanen T, et al. Among authors: brisander m. J Med Chem. 2001 Apr 26;44(9):1337-40. doi: 10.1021/jm0108505. J Med Chem. 2001. PMID: 11311055 No abstract available.

5

Serotonergic and dopaminergic activities of rigidified (R)-aporphine derivatives.

Linnanen T, Brisander M, Mohell N, Johansson AM. Linnanen T, et al. Among authors: brisander m. Bioorg Med Chem Lett. 2001 Feb 12;11(3):367-70. doi: 10.1016/s0960-894x(00)00655-7. Bioorg Med Chem Lett. 2001. PMID: 11212112

6

Diastereoselective reduction of a chiral N-Boc-protected delta-amino-alpha,beta-unsaturated gamma-keto ester Phe-Gly dipeptidomimetic.

Våbenø J, Brisander M, Lejon T, Luthman K. Våbenø J, et al. Among authors: brisander m. J Org Chem. 2002 Dec 27;67(26):9186-91. doi: 10.1021/jo020442o. J Org Chem. 2002. PMID: 12492319

7

Physical characterization of anhydrous and hydrous forms of the hydrochloride salt of BVT.5182 a novel 5-HT(6) receptor antagonist.

Hugerth A, Brisander M, Wrange U, Kritikos M, Norrlind B, Svensson M, Bisrat M, Ostelius J. Hugerth A, et al. Among authors: brisander m. Drug Dev Ind Pharm. 2006 Feb;32(2):185-96. doi: 10.1080/03639040500466122. Drug Dev Ind Pharm. 2006. PMID: 16537199

8

The methanol hemisolvate of amiloride hydrochloride.

Pretscher A, Brisander M, Bauer-Brandl A, Hansen LK. Pretscher A, et al. Among authors: brisander m. Acta Crystallogr C. 2001 Oct;57(Pt 10):1217-9. doi: 10.1107/s0108270101012550. Epub 2001 Oct 12. Acta Crystallogr C. 2001. PMID: 11600791

9

Matrix effects in nilotinib formulations with pH-responsive polymer produced by carbon dioxide-mediated precipitation.

Colombo S, Brisander M, Haglöf J, Sjövall P, Andersson P, Østergaard J, Malmsten M. Colombo S, et al. Among authors: brisander m. Int J Pharm. 2015 Oct 15;494(1):205-17. doi: 10.1016/j.ijpharm.2015.08.031. Epub 2015 Aug 11. Int J Pharm. 2015. PMID: 26276256

10

Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors.

Jesson G, Brisander M, Andersson P, Demirbüker M, Derand H, Lennernäs H, Malmsten M. Jesson G, et al. Among authors: brisander m. Pharm Res. 2014 Mar;31(3):694-705. doi: 10.1007/s11095-013-1191-4. Epub 2013 Aug 30. Pharm Res. 2014. PMID: 23990314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters